SecBot SecBot
8-K ·Filed Feb 27, 2026

BTSG

BrightSpring Health Services, Inc.
BULLISH
Impact 8/10
Horizonweeks Processed8mo ago SEC0001193125-26-078998
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The strong financial performance and robust 2026 guidance suggest BrightSpring is successfully executing its growth strategy in the home healthcare market. Traders should monitor the integration of recent acquisitions and the planned divestiture of the Community Living business, which could create additional value. The share repurchase indicates confidence in the company's valuation.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$41.43
T+0 close · Feb 27, 2026 · via day close
Latest settled
+45.59%
T+60 · $60.32
Vs SPY
+36.21%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Feb 27 $41.43entry
  2. T+1 · 9mo ago +0.36%α +0.31% · $41.58
  3. T+5 · 9mo ago +0.14%α +2.13% · $41.49
  4. T+20 · 8mo ago +2.17%α +9.73% · $42.33
  5. T+60 · 6mo ago +45.59%α +36.21% · $60.32
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BrightSpring Health Services reported strong fourth quarter and full year 2025 financial results, with revenue up 28.2% and net income turning positive at $104.8 million compared to a $68.9 million loss in 2024. The company also initiated 2026 guidance with revenue growth of 11.9%-16.2% and Adjusted EBITDA growth of 23.1%-27.9%, signaling continued momentum in its home and community-based health services business.

Key Financial Metrics

Revenue
$12.9B
+28.2% YoY
EPS
$0.94
Guidance
$14,450 million to $15,000 million
initiated
Gross Margin
11.78%

Key Facts

  • Full year 2025 revenue was $12.911 billion, up 28.2% year-over-year
  • Full year 2025 net income was $104.8 million versus a $68.9 million loss in 2024
  • Full year 2025 Adjusted EBITDA was $618 million, up 34.2% year-over-year
  • 2026 guidance calls for revenue of $14.45-$15.0 billion (11.9%-16.2% growth) and Adjusted EBITDA of $760-$790 million (23.1%-27.9% growth)
  • Company repurchased 1.5 million shares for $43.2 million in connection with a secondary offering

Financial Impact

Revenue increased by $2.839 billion (28.2%) and net income improved by $173.7 million year-over-year, with strong guidance suggesting continued growth momentum

revenueepsebitdaprofitabilitycash flow

Segment Breakdown

SegmentRevenueGrowth
Pharmacy Solutions$11.4B+31.0%
Provider Services$1.5B+11.0%

Risk Factors

  • The company's leverage ratio decreased to 2.99x but remains significant at 2.99x as of December 31, 2025
  • The planned divestiture of the Community Living business to Sevita is expected to close by end of Q1 2026 and could create transition risks
  • Guidance excludes future acquisitions, so M&A activity could alter the outlook

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-078998
Document: btsg-20260227.htm0001193125-26-078998
Document: 0001193125-26-078998-index-headers.html0001193125-26-078998
Document: 0001193125-26-078998-index.html0001193125-26-078998
Document: 0001193125-26-078998.txt0001193125-26-078998

Track record

24 reports on BTSG

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +37.81% at T+60 after the May 1, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $71.36 Now $71.37 +0.01% settles Feb 12
  2. Nov 5, 202611d ago 3 Neutral 2/10 Entry $67.15 Now $71.37 +6.28% settles Feb 4
  3. Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $65.86 Now $71.37 +8.37% settles Feb 3
  4. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $66.89 Now $71.37 +6.70% settles Jan 28
  5. Oct 30, 202617d ago 8-K Bullish 6/10 No price data
  6. Oct 30, 202617d ago Press Release Neutral 5/10 Entry $66.89 Now $71.37 +6.70% settles Jan 28
  7. Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $62.36 Now $71.37 +14.45% settles Jan 19
  8. Oct 1, 20266w ago Press Release Neutral 1/10 Entry $57.26 Now $71.37 +24.64% settles Dec 28
  9. Aug 6, 202614w ago Institutional Cluster Bullish 6/10 Entry $60.60 to $66.89 Now $71.37 +17.77% ▲ +10.38% +12.05% vs SPY
  10. Jul 31, 202615w ago 8-K Bullish 7/10 No price data
Showing 10 of 24

US Market Status

Market Closed · Opens in 6h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 27, 2026